Introduction Hyperlipidaemia is a key modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD) (1). It is commonly characterized by elevated low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), and reduced high-density lipoprotein cholesterol (HDL-C) (1). Statins are the first-line pharmacological therapy, with atorvast
Complicated case of Osteoarthritis
1850 Reached2 Comments3 Likes
Woman presented with Fever of Unknown Origin
7724 Reached93 Comments19 Likes
Case of Pulmonary Embolism with Syncope
544 Reached4 Likes
Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes
Case of Adolescent with Severe Macrocytic Anaemia
52793 Reached502 Comments51 Likes